Galy

About Galy

Galy is a biotechnology firm focused on cellular agriculture, pioneering the development of lab-grown cotton and other plant-derived materials. The company was established in 2019 by co-founders Luciano Braverman and Paula El Koury, who serve as CEO and COO, respectively.

The founders' backgrounds are central to the company's trajectory. Luciano Braverman has a history in the tech industry, including a significant tenure at Microsoft, which informs the company's approach to scaling its biological platform. Paula El Koury brings expertise in design and brand strategy, ensuring the company's sustainable mission resonates within its target market. Their combined experience creates a foundation built on both technological scalability and deep market understanding. The inspiration for Galy reportedly stemmed from a desire to address the significant environmental impact of traditional agriculture.

The core of Galy's business is its proprietary platform that grows plant cells in bioreactors, a process that is independent of climate conditions and traditional land-based farming. This method allows for the creation of materials like cotton without the extensive use of land, water, and pesticides typically required. The company's initial flagship product is a lab-grown cotton aimed at the textile and fashion industries. The primary benefit of this product is its substantially improved sustainability profile; it is produced using significantly less water and land and eliminates the need for pesticides. The process begins with taking a cutting from a plant and identifying the best cells for growth, which are then multiplied in a nutrient-rich liquid medium within bioreactors.

Galy operates on a business-to-business (B2B) model, positioning itself as a supplier of sustainable raw materials to the fashion industry. Its target clients are textile manufacturers and apparel brands seeking to reduce their environmental footprint and enhance supply chain resilience. The company makes money by selling the materials produced through its cellular agriculture process. The addressable market is substantial, given the global scale of cotton production and the increasing consumer and regulatory demand for sustainable fashion.

A significant milestone in the company's history was securing $15.5 million in a seed funding round. This capital infusion is intended to facilitate the scaling of its production capabilities and further research and development into other plant-based materials. This funding underscores investor confidence in Galy's technology and its potential to disrupt the conventional materials market.